XRTX

NASD XORTX Therapeutics, Inc.
Oct 16, 2026 · 7:15 AM ET LAST TRADE Market Closed

$1.46 ↑ +0.04 (+2.63%) Trading Up from the previous close of $1.42

YTD change
-48.14%
vs 20-day SMA
-14.78%
vs 200-day SMA
-34.64%

Price ranges

Previous day
$1.41 $1.54
open $1.53 close $1.42
-$0.11 (-7.19%)
Today
$0.00 $0.00
$1.46
Past week
$1.36 $2.08
from $1.85 now $1.46
-$0.39 (-21.23%)
Past month
$1.36 $2.65
from $1.66 now $1.46
-$0.20 (-12.21%)
This year
$0.35 $3.60
from $2.81 now $1.46
-$1.35 (-48.14%)

Price & Performance

-1.02 (-41.80%) / 6M

$1.28$1.91$2.53$3.16Apr 16Jul 17Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.5% away from all-time highs of $265.05
  • XRTX is down 48% since the beginning of the year
  • XRTX is down 66% over the past 12 months
  • XRTX is down 12% over the past 1 month
  • 1% of all XRTX investors are betting against XRTX

XRTX reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +67.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.05
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.3M
Beta 1.66

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$994.0K
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $7.1M

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $434.03 +1.86%
MRNA Moderna, Inc. $236.50 +4.51%
RVMD Revolution Medicines, Inc. $189.26 -2.20%
ROIV Roivant Sciences Ltd. $34.04 +1.25%
BNTX BioNTech SE Sponsored ADR $90.20 +1.74%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.